Publications
5677 Results
- Journal / Conference
- Journal of Clinical Oncology May 1;40(13):1474-1486
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery and Symptom Management and Survivorship
- PMID
- PMID35119908
- PMC
- PMC9061143
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
- Journal / Conference
- Journal of Clinical Oncology Jan 19;JCO2101506. doi: 10.1200/JCO.21.01506. Online ahead of print
- Year
- 2022
- Research Committee(s)
- Breast
- PMID
- PMID35044810
- Study Number(s)
- CTSU/C40603
CALGB/Alliance 40603: Long-term outcomes after neoadjuvant chemotherapy with or without carboplatin and bevacizumab in triple-negative breast cancer (TNBC)
- Journal / Conference
- PLOS Medicine Feb 3;19(2):e1003897
- Year
- 2022
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID35113855
- PMC
- PMC8812899
- Study Number(s)
- S0000
Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers
- Journal / Conference
- BMC Medicine Jan 11;20(1):3
- Year
- 2022
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID35012533
- PMC
- PMC8750876
- Study Number(s)
- S0000, SWOG-9217
Circulating Inflammatory Cytokines and Risk of Five Cancers: a Mendelian Randomization Analysis
- Journal / Conference
- PLOS Medicine Jan 27;19(1):e1003859. doi: 10.1371/journal.pmed.1003859. eCollection 2022 Jan
- Year
- 2022
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID35085228
- PMC
- PMC8794090
- Study Number(s)
- S0000, SWOG-9217
The relationship between Lipoprotein A and Prostate Cancer risk: A multivariable Mendelian randomization study
- Journal / Conference
- Obesity Jan;30(1):28-38
- Year
- 2022
- Research Committee(s)
- Breast
- PMID
- PMID34932888
- Study Number(s)
- CTSU/A011401
The Breast Cancer Weight Loss (BWEL) Trial (Alliance 011401): A Description of the Lifestyle Intervention
- Journal / Conference
- Clinical Cancer Research Apr 14;28(8):1690-1700
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID35176136
- PMC
- PMC9093780
- Study Number(s)
- CTSU/C80405
Tumor immunogenomic features determine outcomes in patients with metastatic colorectal cancer of CALGB/SWOG 80405 (Alliance) treated with standard-of-care combinations of bevacizumab and cetuximab
- Journal / Conference
- Frontiers in Oncology Jan 14;11:808715
- Year
- 2022
- Research Committee(s)
- Cancer Control
- PMID
- PMID35096612
- PMC
- PMC8795906
- Study Number(s)
- SWOG-9217
Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial
- Journal / Conference
- Prostate Cancer and Prostatic Diseases Apr;25(4):755-761
- Year
- 2022
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID35152271
- PMC
- PMC9372232
- Study Number(s)
- SWOG-9217
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
- Journal / Conference
- Lancet Oncology Feb;23(2):259-269
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID35038433
- Study Number(s)
- CTSU/R1010